Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jessica J. Lin

Brief Report: Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET -Rearranged Lung Cancers

Journal of Thoracic Oncology

English

Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC

Journal of Thoracic Oncology

English

Related publications

Miliary Brain Metastases in a Patient With ROS1-Rearranged Lung Adenocarcinoma: A Case Report

Journal of Thoracic Oncology

English

Association of Genetic and Immuno-Characteristics With Clinical Outcomes in Patients With RET-rearranged Non-Small Cell Lung Cancer: A Retrospective Multicenter Study

Journal of Hematology and Oncology

English

P081 Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients

Journal of Thoracic Oncology

English

Targeted Sequencing and Intracranial Outcomes of Patients With Lung Adenocarcinoma Brain Metastases Treated With Radiotherapy

English

RET-Rearranged Lung Adenocarcinomas With Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib

Journal of Thoracic Oncology

English

The Activity, Safety, and Evolving Role of Brigatinib in Patients With ALK-rearranged Non-Small Cell Lung Cancers

OncoTargets and Therapy

Oncology

Pharmacology

2017

English

Efficacy and Safety of Icotinib in Patients With Brain Metastases From Lung Adenocarcinoma

OncoTargets and Therapy

Oncology

Pharmacology

2016

English

Survival of Patients With Non-Small Cell Lung Cancer and Brain Metastases

English

P071 Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jessica J. Lin

Brief Report: Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET -Rearranged Lung Cancers

Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC

Related publications

Miliary Brain Metastases in a Patient With ROS1-Rearranged Lung Adenocarcinoma: A Case Report

Association of Genetic and Immuno-Characteristics With Clinical Outcomes in Patients With RET-rearranged Non-Small Cell Lung Cancer: A Retrospective Multicenter Study

P081 Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients

Targeted Sequencing and Intracranial Outcomes of Patients With Lung Adenocarcinoma Brain Metastases Treated With Radiotherapy

RET-Rearranged Lung Adenocarcinomas With Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib

The Activity, Safety, and Evolving Role of Brigatinib in Patients With ALK-rearranged Non-Small Cell Lung Cancers

Efficacy and Safety of Icotinib in Patients With Brain Metastases From Lung Adenocarcinoma

Survival of Patients With Non-Small Cell Lung Cancer and Brain Metastases

P071 Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers